The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kananovich P.S.

Mental Health Research Center, Moscow, Russia

Barkhatova A.N.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN, Moskva

A history and overview of anhedonia in endogenous mental disorders

Authors:

Kananovich P.S., Barkhatova A.N.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(3): 96‑101

DOI: 10.17116/jnevro20171173196-101

Views: 8361

Downloaded: 128

Download PDF (RU)
Contact the author
Table of contents

A HISTORY AND OVERVIEW OF ANHEDONIA IN ENDOGENOUS MENTAL DISORDERS
A HISTORY AND OVERVIEW OF ANHEDONIA IN ENDOGENOUS MENTAL DISORDERS

To cite this article:

Kananovich PS, Barkhatova AN. A history and overview of anhedonia in endogenous mental disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(3):96‑101. (In Russ.)
https://doi.org/10.17116/jnevro20171173196-101

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry)
 
 
МСФ на ЯМ
Close metadata
Recommended articles:
Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):22-30
Asthenia in young patients and possibilities for its correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):133-137
Sleep diso­rders and onco­logical diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):125-131
Reco­gnan (citicoline) in the correction of asthenic and anxiety-depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):43-47
Fluvoxamine in the treatment of anxiety-depressive spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):101-109
Anti­depressants in psychiatric practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):126-132
Controversial issues of diagnosis and theoretical concepts of schi­zophrenia in childhood. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):17-24
Psychological concepts — design of clinical models of schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):25-31
Pharmacotherapy of schi­zophrenia: clinical and some age-related aspe­cts. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):41-50
Clinical systematics of chro­nic delu­sional psychoses in schi­zophrenia and schi­zophrenia-spectrum pathology. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):65-74

Anhedonia is the inability to experience pleasure. This disorder is heterogeneous across psychiatric disorders and is difficult for measuring and submitting to scientific analysis. Over the last several decades there has been increasing interest in the role that anhedonia plays in various psychopathologies. This article reviews the recent literature on anhedonia and its psychopathological features, which are important for prognosis in affective disorders and schizophrenia. Attempts to dissect various subtypes of anhedonia observed in negative syndrome and depression are reviewed as well.

Keywords:

anhedonia
schizophrenia
negative symptoms
affective disorders
depression

Authors:

Kananovich P.S.

Mental Health Research Center, Moscow, Russia

Barkhatova A.N.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN, Moskva

List of references:

  1. Ribo TA. Psikhologiya chuvstv. Per. s fr. M.: Gol'dsmit. SPb.: Izd. F. Pavlenkova; 1898. (In Russ.).
  2. Krepelin E. Vvedenie v psikhiatricheskuyu kliniku. M.: BINOM. Laboratoriya znanii; 2004;493. (In Russ.).
  3. Bleuler E. Rukovodstvo po psikhiatrii. M.: Izdatel'stvo Nezavisimoi psikhiatricheskoi assotsiatsii; 1920. Reprintnoe vosproizvedenie izdaniya: Berlin: Izdatel'stvo t-va «Vrach»; 1920. (In Russ.).
  4. Myerson A. Anhedonia. Am J Psychiatry. 1922;79(1):87-103. doi: 10.1176/ajp.79.1.87
  5. Snezhnevskii AV. Mesto kliniki v issledovanii prirody shizofrenii. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1975;75(9):1340-1345. (In Russ.).
  6. van Praag H, Uleman A, Spitz J. The vital syndrome interview. A structured standard interview for the recognition and registration of the vital depressive symptom complex. Psychiatr Neurol Neurochir. 1965;68(5):329-346.
  7. Klein D. Endogenomorphic Depression. Arch Gen Psychiatry. 1974;31(4):447. doi: 10.1001/archpsyc.1974.01760160005001
  8. Harrison A, Mountford V, Tchanturia K. Social anhedonia and work and social functioning in the acute and recovered phases of eating disorders. Psychiatry Research. 2014;218(1-2):187-194. doi: 10.1016/j.psychres.2014.04.007
  9. Isella V. Physical anhedonia in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry. 2003;74(9):1308-1311. doi: 10.1136/jnnp.74.9.1308
  10. James W. The Varieties Of Religious Experience. London: Longmans, Green & Co.; 1902.
  11. Krylov VI. Anhedonia affective and schizophrenia spectrum disorders: psychopathological features, diagnostic and prognostic value. Psihiatrija i psihofarmakoterapija im. P.B. Gannushkina. 2014;01. (In Russ.).
  12. Snaith P. Anhedonia: a neglected symptom of psychopathology. Psychological Medicine. 1993;23(04):957. doi: 10.1017/s0033291700026428
  13. Rado S. Psychoanalysis Of Behaviour. Collected Papers. Grune & Stratton: New York, London; 1956.
  14. Meehl P. Schizotaxia, schizotypy, schizophrenia. American Psychologist. 1962;17(12):827-838. doi: 10.1037/h0041029
  15. Kwapil T. Social anhedonia as a predictor of the development of schizophrenia-spectrum disorders. Journal of Abnormal Psychology. 1998;107(4):558-565. doi: 10.1037/0021-843x.107.4.558
  16. Chapman L, Chapman J, Kwapil T, Eckblad M, et al. Putatively psychosis-prone subjects 10 years later. Journal of Abnormal Psychology. 1994;103(2):171-183. doi: 10.1037/0021-843x.103.2.171
  17. Schürhoff F, Szöke A, Bellivier F et al. Anhedonia in schizophrenia: a distinct familial subtype? Schizophrenia Research. 2003;61(1):59-66. doi: 10.1016/s0920-9964(02)00237-2
  18. Silvia PJ, Kwapil TR. Aberrant asociality: how individual differences in social anhedonia illuminate the need to belong. J Pers. 2011;79(6):1315-1332. doi: 10.1111/j.1467-6494.2010.00702.x
  19. Tallent K, Gooding D. Working memory and Wisconsin Card Sorting Test performance in schizotypic individuals: a replication and extension. Psychiatry Research. 1999;89(3):161-170. doi: 10.1016/s0165-1781(99)00101-8
  20. Gooding D, Tallent K, Matts C. Clinical Status of At-Risk Individuals% Years Later: Further Validation of the Psychometric High-Risk Strategy. Journal of Abnormal Psychology. 2005;114(1):170-175. doi: 10.1037/0021-843x.114.1.170
  21. Cohen A, Emmerson L, Mann M, Forbes C, Blanchard J. Schizotypal, schizoid and paranoid characteristics in the biological parents of social anhedonics. Psychiatry Research. 2010;178(1):79-83. doi: 10.1016/j.psychres.2008.07.018
  22. Horan W, Blanchard J, Gangestad S, Kwapil T. The Psychometric Detection of Schizotypy: Do Putative Schizotypy Indicators Identify the Same Latent Class? Journal of Abnormal Psychology. 2004;113(3):339-357. doi: 10.1037/0021-843x.113.3.339
  23. Strauss G, Gold J. A New Perspective on Anhedonia in Schizophrenia. American Journal of Psychiatry. 2012;169(4):364-373. doi: 10.1176/appi.ajp.2011.11030447
  24. Ey H. Etudes Psychiatriques. Paris; 1954, 787.
  25. Blanchard J, Gangestad S, Brown S, Horan W. Hedonic capacity and schizotypy revisited: A taxometric analysis of social anhedonia. Journal of Abnormal Psychology. 2000;109(1):87-95. doi: 10.1037/0021-843x.109.1.87
  26. Cressman V, Schobel S, Steinfeld S et al. Anhedonia in the psychosis risk syndrome: associations with social impairment and basal orbitofrontal cortical activity. npj Schizophrenia. 2015;1:15020. doi: 10.1038/npjschz.2015.20
  27. Blanchard J, Mueser K, Bellack A. Anhedonia, Positive and Negative Affect, and Social Functioning in Schizophrenia. Schizophrenia Bulletin. 1998;24(3):413-424. doi: 10.1093/oxfordjournals.schbul.a033336
  28. Herbener E, Harrow M, Hill S. Change in the relationship between anhedonia and functional deficits over a 20-year period in individuals with schizophrenia. Schizophrenia Research. 2005;75(1):97-105. doi: 10.1016/j.schres.2004.12.013
  29. Velthorst E, Meijer C. The association between social anhedonia, withdrawal and psychotic experiences in general and high-risk populations. Schizophrenia Research. 2012;138(2-3):290-294. doi: 10.1016/j.schres.2012.03.022
  30. Bumke O. Skhizofreniya. M. 1933. Pper. s nem. Handbuch der Geisteskrankheiten. hrsg. v. O. Bumke, B. IX, Berlin: Springer, 1932. (In Russ.).
  31. Suslow T, Roestel C, Ohrmann P, Arolt V. The experience of basic emotions in schizophrenia with and without affective negative symptoms. Comprehensive Psychiatry. 2003;44(4):303-310. doi: 10.1016/s0010-440x(03)00085-3
  32. Carpenter WT Jr, Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: the concept. American Journal of Psychiatry. 1988;145(5):578-583. doi: 10.1176/ajp.145.5.578
  33. Kirkpatrick B, Buchanan R, McKenny P, Alphs L, Carpenter W. The schedule for the deficit syndrome: An instrument for research in schizophrenia. Psychiatry Research. 1989;30(2):119-123. doi: 10.1016/0165-1781(89)90153-4
  34. Andreasen N. Negative Symptoms in Schizophrenia. Arch Gen Psychiatry. 1982;39(7):784. doi: 10.1001/archpsyc.1982.04290070020005
  35. Strauss G, Horan W, Kirkpatrick B et al. Deconstructing negative symptoms of schizophrenia: Avolition — apathy and diminished expression clusters predict clinical presentation and functional outcome. Journal of Psychiatric Research. 2013;47(6):783-790. doi: 10.1016/j.jpsychires.2013.01.015
  36. Foussias G, Agid O, Fervaha G, Remington G. Negative symptoms of schizophrenia: Clinical features, relevance to real world functioning and specificity versus other CNS disorders. European Neuropsychopharmacology. 2014;24(5):693-709. doi: 10.1016/j.euroneuro.2013.10.017
  37. Foussias G, Remington G. Negative Symptoms in Schizophrenia: Avolition and Occam's Razor. Schizophrenia Bulletin. 2008;36(2):359-369. doi: 10.1093/schbul/sbn094
  38. Ritsner M, Arbitman M, Lisker A. Anhedonia Is an Important Factor of Health-Related Quality-of-Life Deficit in Schizophrenia and Schizoaffective Disorder. The Journal of Nervous and Mental Disease. 2011;199(11):845-853. doi: 10.1097/nmd.0b013e3182349ce6
  39. Keltner D, Kring A. Emotion, social function, and psychopathology. Review of General Psychology. 1998;2(3):320-342. doi: 10.1037/1089-2680.2.3.320
  40. Herbener E, Harrow M. The course of anhedonia during 10 years of schizophrenic illness. Journal of Abnormal Psychology. 2002;111(2):237-248. doi: 10.1037/0021-843x.111.2.237
  41. Fortunati R, Ossola P, Camerlengo A et al. Anhedonia in schizophrenia: The role of subjective experiences. Comprehensive Psychiatry. 2015;62:152-160. doi: 10.1016/j.comppsych.2015.07.011
  42. Schuck J, Leventhal D, Rothstein H, Irizarry V. Physical anhedonia and schizophrenia. Journal of Abnormal Psychology. 1984;93(3):342-344. doi: 10.1037/0021-843x.93.3.342
  43. Blanchard J, Horan W, Brown S. Diagnostic differences in social anhedonia: A longitudinal study of schizophrenia and major depressive disorder. Journal of Abnormal Psychology. 2001;110(3):363-371. doi: 10.1037/0021-843x.110.3.363
  44. Cohen A, Minor K. Emotional Experience in Patients With Schizophrenia Revisited: Meta-analysis of Laboratory Studies. Schizophrenia Bulletin. 2008;36(1):143-150. doi: 10.1093/schbul/sbn061
  45. Llerena K, Strauss G, Cohen A. Looking at the other side of the coin: A meta-analysis of self-reported emotional arousal in people with schizophrenia. Schizophrenia Research. 2012;142(1-3):65-70. doi: 10.1016/j.schres.2012.09.005
  46. Gard D, Kring A, Gard M, Horan W, Green M. Anhedonia in schizophrenia: Distinctions between anticipatory and consummatory pleasure. Schizophrenia Research. 2007;93(1-3):253-260. doi: 10.1016/j.schres.2007.03.008
  47. Gard D, Gard M, Kring A, John O. Anticipatory and consummatory components of the experience of pleasure: A scale development study. Journal of Research in Personality. 2006;40(6):1086-1102. doi: 10.1016/j.jrp.2005.11.001
  48. Oorschot M, Lataster T, Thewissen V et al. Emotional Experience in Negative Symptoms of Schizophrenia — No Evidence for a Generalized Hedonic Deficit. Schizophrenia Bulletin. 2011;39(1):217-225. doi: 10.1093/schbul/sbr137
  49. Horan W, Kring A, Blanchard J. Anhedonia in Schizophrenia: A Review of Assessment Strategies. Schizophrenia Bulletin. 2005;32(2):259-273. doi: 10.1093/schbul/sbj009
  50. Gold J, Waltz J, Prentice K, Morris S, Heerey E. Reward Processing in Schizophrenia: A Deficit in the Representation of Value. Schizophrenia Bulletin. 2008;34(5):835-847. doi: 10.1093/schbul/sbn068
  51. Barch D, Pagliaccio D, Luking K. Mechanisms Underlying Motivational Deficits in Psychopathology: Similarities and Differences in Depression and Schizophrenia. Behavioral Neuroscience of Motivation. 2015:411-449. doi: 10.1007/7854_2015_376
  52. Treadway M, Zald D. Reconsidering anhedonia in depression: Lessons from translational neuroscience. Neuroscience & Biobehavioral Reviews. 2011;35(3):537-555. doi: 10.1016/j.neubiorev.2010.06.006
  53. Burbridge J, Barch D. Anhedonia and the experience of emotion in individuals with schizophrenia. Journal of Abnormal Psychology. 2007;116(1):30-42. doi: 10.1037/0021-843x.116.1.30
  54. Heinrichs R, Zakzanis K. Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropsychology. 1998;12(3):426-445. doi: 10.1037/0894-4105.12.3.426
  55. Cohen A, Najolia G, Brown L, Minor K. The state-trait disjunction of anhedonia in schizophrenia: Potential affective, cognitive and social-based mechanisms. Clinical Psychology Review. 2011;31(3):440-448. doi: 10.1016/j.cpr.2010.11.001
  56. Neumann A, Blairy S, Lecompte D, Philippot P. Specificity deficit in the recollection of emotional memories in schizophrenia. Consciousness and Cognition. 2007;16(2):469-484. doi: 10.1016/j.concog.2006.06.014
  57. Heerey E, Gold J. Patients with schizophrenia demonstrate dissociation between affective experience and motivated behavior. Journal of Abnormal Psychology. 2007;116(2):268-278. doi: 10.1037/0021-843x.116.2.268
  58. Prentice K, Gold J, Buchanan R. The Wisconsin Card Sorting impairment in schizophrenia is evident in the first four trials. Schizophrenia Research. 2008;106(1):81-87. doi: 10.1016/j.schres.2007.07.015
  59. Herbener E. Emotional Memory in Schizophrenia. Schizophrenia Bulletin. 2008;34(5):875-887. doi: 10.1093/schbul/sbn081
  60. Akiskal HS, Weise RE. The clinical spectrum of so-called «minor» depressions. Am J Psychother. 1992;46(1):9-22.
  61. Loas G. Vulnerability to depression: A model centered on anhedonia. Journal of Affective Disorders. 1996;41(1):39-53. doi: 10.1016/0165-0327(96)00065-1
  62. Blanchard J, Collins L, Aghevli M, Leung W, Cohen A. Social Anhedonia and Schizotypy in a Community Sample: The Maryland Longitudinal Study of Schizotypy. Schizophrenia Bulletin. 2009;37(3):587-602. doi: 10.1093/schbul/sbp107
  63. ESQUIROL J, Mental Maladies. A Treatise On Insanity. Translated From The French With Additions By E.K. Hunt. Philadelphia; 1845.
  64. Grizinger V. Dushevnye bolezni: O raspoznavanii i lechenii sumasshestviya. Per. s nem. Pod red. Ovsyannikova F.V. M.: Knizhnyi dom «LIBROKOM»; 2012. (In Russ.).
  65. Tsirkin S. Analiticheskaya psikhopatologiya. M.: Binom; 2012. (In Russ.).
  66. Siris S. Depression in Schizophrenia: Perspective in the Era of «Atypical» Antipsychotic Agents. American Journal of Psychiatry. 2000;157(9):1379-1389. doi: 10.1176/appi.ajp.157.9.1379
  67. Hausmann A, Fleischhacker W. Depression in Patients with Schizophrenia. CNS Drugs. 2000;14(4):289-299. doi: 10.2165/00023210-200014040-00004
  68. Stein DJ. Depression, anhedonia, and psychomotor symptoms: the role of dopaminergic neurocircuitry. CNS Spectr. 2008;13(7):561-565.
  69. Hirsch S, Gaind R, Rohde P, Stevens B, Wing J. Outpatient Maintenance of Chronic Schizophrenic Patients with Long-acting Fluphenazine: Double-blind Placebo. BMJ. 1973;1(5854):633-637. doi: 10.1136/bmj.1.5854.633
  70. Johnson D. Studies of depressive symptoms in schizophrenia. The British Journal of Psychiatry. 1981;139(2):89-101. doi: 10.1192/bjp.139.2.89
  71. Judd L, Schettler P, Akiskal H et al. Residual Symptom Recovery From Major Affective Episodes in Bipolar Disorders and Rapid Episode Relapse/Recurrence. Arch Gen Psychiatry. 2008;65(4):386. doi: 10.1001/archpsyc.65.4.386
  72. Kennedy N, Foy K. The impact of residual symptoms on outcome of major depression. Current Psychiatry Reports. 2005;7(6):441-446. doi: 10.1007/s11920-005-0065-9
  73. Vertogradova OP, Petukhov VV. Zatyazhnye depressii (zakonomernosti formirovaniya, prognoz, terapiya). Sotsial'naya i klinicheskaya psikhiatriya. 2005;4. (In Russ.).
  74. Zakharova NV. Remissii pri rekurrentnom depressivnom rasstroistve (epidemiologiya, tipologicheskaya differentsiatsiya, terapiya): Dis. ... . kand. med. nauk. M. 2015. (In Russ.). http://www.psychiatry.ru/cond/0/diss/2015/249
  75. Kirkpatrick B, Fenton W, Carpenter W, Marder S. The NIMH-MATRICS Consensus Statement on Negative Symptoms. Schizophrenia Bulletin. 2006;32(2):214-219. doi: 10.1093/schbul/sbj053
  76. Mulholland C. The symptom of depression in schizophrenia and its management. Advances in Psychiatric Treatment. 2000;6(3):169-177. doi: 10.1192/apt.6.3.169

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.